Breaking News Bar

Business News and Information

FDA approves Aerie drug sooner than expected – sales staff to grow

For Aerie Pharmaceuticals (Nasdaq: AERI) – a Duke University spinout that is in the process of building out its research and development team locally – Christmas did indeed come early.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear